Medicine
Clinical care, treatments, medical research, and practitioner guidance.
Ebola outbreak in Congo and Uganda tops 900 suspected cases, WHO says
The World Health Organization and CDC say an Ebola outbreak in the Democratic Republic of the Congo and Uganda remains active, with suspected cases in eastern Congo climbing past 900 and 119 deaths reported by authorities.
Global Alzheimer’s Platform Foundation expands Bio-Hermes-002 study with Sanofi
The Global Alzheimer’s Platform Foundation said Sanofi is joining the expanded Bio-Hermes-002 study, which combines blood-based and digital biomarkers with MRI and PET imaging to improve Alzheimer’s prediction, detection and diagnosis.
Lucideon launches new biocompatibility lab in Greenville
Lucideon says it has opened a dedicated U.S. biocompatibility laboratory in Greenville, South Carolina, adding testing capacity for medical devices and biomaterials. The facility will support cytotoxicity, extractables and leachables, toxicological risk assessment, surface characterization and other regulatory testing services.
Philips introduces SmartIQ for coronary procedures
Philips has launched SmartIQ, a coronary imaging technology for its Azurion platform that it says can reduce X-ray exposure while preserving image quality. The company plans to show the system at EuroPCR 2026 in Paris.
FDA Approves Baxdrostat for Uncontrolled Hypertension on Background Therapy
The FDA approved AstraZeneca’s baxdrostat, sold as Baxfendy, for adults with hypertension that remains uncontrolled on existing blood pressure medicines. The approval is based on the BaxHTN phase 3 trial and marks the first U.S. approval of an aldosterone synthase inhibitor.
EmStop starts CAPTURE-2 IDE clinical trial
EmStop said it has initiated the CAPTURE-2 Investigational Device Exemption clinical trial of its embolic protection system for TAVR, with first cases completed at Mission Hospital in Asheville. The study is listed in CMS and ClinicalTrials.gov records and builds on earlier feasibility work at the same hospital.
Abortion bans linked to worse miscarriage care in JAMA study
A new JAMA study found that after Dobbs, commercially insured patients with first-trimester miscarriages in states with trigger abortion bans were less likely to receive medication management and more likely to be managed expectantly.
American Heart Association urges international coordination on Kawasaki disease
The American Heart Association has issued a science advisory calling for stronger international coordination on Kawasaki disease, saying shared research, earlier diagnosis and more consistent care could reduce heart complications and disparities worldwide.
Chromatin tracking reveals two motion modes that help control gene expression
MIT researchers reported in Nature that chromatin moves in two distinct ways across cell types, based on MINFLUX tracking in living cells. The findings may help explain how cells search for gene-regulating partners and repair DNA damage.
World going too slow on eliminating hepatitis: WHO
The World Health Organization says hepatitis elimination efforts are improving, but still lag badly behind what is needed to meet 2030 targets.
Lundbeck presents new data at AAN 2026 on migraine-related cognitive symptoms
Lundbeck said it presented new data at the 2026 American Academy of Neurology annual meeting in Chicago from the INFUSE real-world study of Vyepti (eptinezumab). The company said patients reported improvements in migraine-related cognitive symptoms after treatment, including brain fog and difficulty making decisions.
NYU Langone neurologists present latest clinical findings at AAN 2026
NYU Langone Health’s Department of Neurology is presenting more than 80 talks and posters at the AAN 2026 annual meeting in Chicago, including phase 3 X-TOLE2 results for azetukalner in focal onset seizures and a qualitative study on barriers faced by patients with disabilities in outpatient neurology settings.
AACR announces recipients of Trailblazer Cancer Research Grants
The American Association for Cancer Research named 15 recipients of its Trailblazer Cancer Research Grants during the opening ceremony of AACR Annual Meeting 2026 in San Diego. Nine early-stage investigators and six mid-career investigators will each receive $1 million over three years to support cancer biology, translational science, and patient-outcome research.
FDA posts nationwide recall of Blaine Labs wound care gels
The FDA posted a nationwide recall of Blaine Labs wound care gels after testing found Lysinibacillus fusiformis contamination in three lots.
NIH says low-cost team-based care lowered blood pressure in high-risk patients
An NIH-supported trial in 36 federally qualified health centers found that a team-based hypertension care model lowered blood pressure more than enhanced usual care, at an average cost of about $760 per patient.
American Cancer Society launches new pediatric, adolescent and young adult cancer journal
The American Cancer Society has launched a new open-access journal focused on pediatric, adolescent and young adult cancer.
April 7, 2026 issue of JAMA
JAMA’s April 7 issue includes two randomized trials with potential practice implications in stroke care and brain metastases radiation.
FDA launches READI-Home innovation challenge for home-use medical devices
The FDA has opened a challenge for home-use medical devices aimed at reducing avoidable readmissions after hospital treatment.
NRC logs Browns Ferry Unit 3 reactor protection system actuation in April 7 event report
The NRC’s April 7 event report includes a Browns Ferry Unit 3 reactor protection system actuation, with no reported impact on public health or safety.
UT Health San Antonio reports trial results for combat PTSD treatment
UT Health San Antonio says a clinical trial found that adding navigated TMS to psychotherapy reduced PTSD symptoms in combat-related cases.
Public trust in AI in health care is slipping, survey finds
A new Ohio State survey finds fewer adults are comfortable with AI in health care, while many still use it for symptom checks and health decisions.
American College of Osteopathic Family Physicians to hold disease prevention summit in Orlando on April 15
ACOFP says it will host its first Disease Prevention Summit in Orlando on April 15 as part of its annual convention.